Pharmaceutical - Pharmaceutical, Newron Pharma

Filter

Popular Filters

Newron and Zambon file safinamide NDA with FDA

Newron and Zambon file safinamide NDA with FDA

30-05-2014

Italian drug developer Newron Pharmaceuticals and its partner, family-owned Italian drugmaker Zambon…

NeurologicalNewron PharmaPharmaceuticalRegulationsafinamideUSAZambon

Safinamide marketing application submitted to Swissmedic

07-04-2014

Italian drug developer Newron Pharmaceuticals and its partner, family-owned Italian drugmaker Zambon…

Markets & MarketingNeurologicalNewron PharmaNorthern EuropePharmaceuticalRegulationsafinamideZambon

Patent expiries will push Parkinson’s drug market lower by 2019

17-12-2013

Due to upcoming patent expirations for four high-profile drugs, the global Parkinson’s disease (PD)…

GlobalImpax LaboratoriesMarkets & MarketingNeurologicalNewron PharmaPatentsPharmaceuticalpimavanserinRytarysafinamide

Newron and Zambon file for EU approval of Parkinson’s drug safinamide

09-12-2013

Italian drug developer Newron Pharmaceuticals and its partner, family-owned Italian drugmaker Zambon…

EuropeNeurologicalNewron PharmaNorth AmericaPharmaceuticalRegulationsafinamideZambon

Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD

19-06-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) and US partner Bristol-Myers Squibb have announced mixed…

AstraZenecaBristol-Myers SquibbDiabetesNeurologicalNewron PharmaOnglyzaPharmaceuticalResearchsafinamideZambon

Flurry of M&A activity in Europe, with takeovers for NeuroNova and Proximagen

13-06-2012

This morning saw a flurry of acquisition announcements by pharma companies. First up, Italy's Newron…

ApreaIndustrifondenKarolinska DevelopmentMergers & AcquisitionsNeuroNovaNewron PharmaOncopeptidesPharmaceuticalProximagenUpsher-Smith

Newron executes safinamide deal with Zambon; new Ph III data; management changes

15-05-2012

In what was a busy news day for Italian drug developer Newron Pharmaceuticals SpA (SIX: NWRN), the company…

FinancialLicensingManagementNeurologicalNewron PharmaPharmaceuticalResearchsafinamideZambon

Newron licenses safinamide to Zambon for EU and USA

09-04-2012

Italian drug developer Newron Pharmaceuticals (SIX: NWRN) says that it has signed a strategic collaboration…

LicensingMergers & AcquisitionsNeurologicalNewron PharmaPharmaceuticalsafinamideZambon

COMPANY SPOTLIGHT

Menarini

Back to top